Biofil Chemicals Pharmaceuticals Stock Fundamentals
| BIOFILCHEM | 43.66 0.35 0.81% |
Biofil Chemicals Pharmaceuticals fundamentals help investors to digest information that contributes to Biofil Chemicals' financial success or failures. It also enables traders to predict the movement of Biofil Stock. The fundamental analysis module provides a way to measure Biofil Chemicals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Biofil Chemicals stock.
At present, Biofil Chemicals' Other Operating Expenses is projected to increase significantly based on the last few years of reporting. The current year's Operating Income is expected to grow to about 24.9 M, whereas Depreciation And Amortization is forecasted to decline to about 3.1 M. Biofil | Select Account or Indicator |
Biofil Chemicals Pharmaceuticals Company Operating Margin Analysis
Biofil Chemicals' Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Biofil Chemicals Operating Margin | 0.02 % |
Most of Biofil Chemicals' fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Biofil Chemicals Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, Biofil Chemicals Pharmaceuticals has an Operating Margin of 0.0163%. This is much higher than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The operating margin for all India stocks is notably lower than that of the firm.
Biofil Chemicals Pha Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Biofil Chemicals's current stock value. Our valuation model uses many indicators to compare Biofil Chemicals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Biofil Chemicals competition to find correlations between indicators driving Biofil Chemicals's intrinsic value. More Info.Biofil Chemicals Pharmaceuticals is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.36 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Biofil Chemicals Pharmaceuticals is roughly 2.78 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Biofil Chemicals by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Biofil Chemicals' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Biofil Operating Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Biofil Chemicals' direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Biofil Chemicals could also be used in its relative valuation, which is a method of valuing Biofil Chemicals by comparing valuation metrics of similar companies.Biofil Chemicals is currently under evaluation in operating margin category among its peers.
Biofil Fundamentals
| Return On Equity | 0.04 | ||||
| Return On Asset | 0.0144 | ||||
| Profit Margin | 0.01 % | ||||
| Operating Margin | 0.02 % | ||||
| Current Valuation | 712.37 M | ||||
| Shares Outstanding | 16.27 M | ||||
| Shares Owned By Insiders | 59.77 % | ||||
| Price To Book | 3.83 X | ||||
| Price To Sales | 1.76 X | ||||
| Revenue | 400.35 M | ||||
| Gross Profit | 25.29 M | ||||
| EBITDA | 13.06 M | ||||
| Net Income | 7.09 M | ||||
| Cash And Equivalents | 260 K | ||||
| Total Debt | 4.39 M | ||||
| Book Value Per Share | 11.40 X | ||||
| Cash Flow From Operations | 23.94 M | ||||
| Earnings Per Share | 0.38 X | ||||
| Number Of Employees | 26 | ||||
| Beta | 1.97 | ||||
| Market Capitalization | 715.76 M | ||||
| Total Asset | 470.83 M | ||||
| Retained Earnings | (316.94 M) | ||||
| Working Capital | 98.83 M | ||||
| Net Asset | 470.83 M |
About Biofil Chemicals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Biofil Chemicals Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biofil Chemicals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biofil Chemicals Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 1.7 M | 1.7 M | |
| Total Revenue | 460.4 M | 483.4 M | |
| Cost Of Revenue | 431.3 M | 452.9 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Biofil Stock
Biofil Chemicals financial ratios help investors to determine whether Biofil Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biofil with respect to the benefits of owning Biofil Chemicals security.